DNA sequencing found to be better than flow cytometry in predicting cancer relapse

In a recent study Scientists at  University of Washington, University of New Mexico Health Sciences Center, University of Virginia,  University of California and  Fred Hutchinson Cancer Research Center have found that  high-throughput sequencing could improve the diagnosis and post-treatment monitoring of leukemia. The sequencing-based method is more sensitive than flow cytometry and cheaper  and faster than the quantitative real-time PCR. They used high throughput sequencing (HTS)  to the diagnosis of T-lineage acute lymphoblastic leukemia/lymphoma. 43 paired patient samples were used for assessing